Advertisement
Screener

AVITA Medical, Inc. (RCEL) Stock Issued During Period, Value, Stock Options Exercised

2.6 / 5 stars · 32/61 Roast Me

AVITA Medical, Inc. Stock Issued During Period, Value, Stock Options Exercised

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • AVITA Medical, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
  • AVITA Medical, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $33.00K, a 96.73% decline year-over-year.
  • AVITA Medical, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $11.00K, a 82.54% decline year-over-year.
  • AVITA Medical, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $363.00K, a 42.47% decline year-over-year.
  • AVITA Medical, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $407.00K, a 80.94% decline from fiscal 2024.
  • AVITA Medical, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $2.13M, a 123.09% increase from fiscal 2023.
  • AVITA Medical, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $957.00K, a 6.33% increase from fiscal 2022.
  • AVITA Medical, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $900.00K.
Period endStock Issued During Period, Value, Stock Options Exercised 3 monthStock Issued During Period, Value, Stock Options Exercised 12 month
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$407.00K
10-K · filed 2026-02-12
2025-09-30$33.00K
10-Q · filed 2025-11-06
$841.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$11.00K
10-Q · filed 2026-08-06
$1.82M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$363.00K
10-Q · filed 2026-05-14
$1.87M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$434.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$2.13M
10-K · filed 2026-02-12
2024-09-30$1.01M
10-Q · filed 2025-11-06
$1.72M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$63.00K
10-Q · filed 2025-08-08
$819.00K
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31$631.00K
10-Q · filed 2025-05-08
$1.42M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$15.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$957.00K
10-K · filed 2025-02-13
2023-09-30$110.00K
10-Q · filed 2024-11-07
$1.84M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$661.00K
10-Q · filed 2024-08-08
$1.73M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$171.00K
10-Q · filed 2024-05-13
$1.07M
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31$899.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$900.00K
10-K · filed 2024-02-22
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$5.00K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$8.00K
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$1.00K
10-Q · filed 2023-05-11
$40.00K
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$4.00K
derived: 10-K 6 month − 10-Q 3 month · filed 2023-02-23
$70.00K
derived: sum of 4 quarters · filed 2023-02-23
2021-09-30$3.00K
10-Q · filed 2022-11-10
$67.00K
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$32.00K
10-Q · filed 2022-08-11
$63.00K
10-K · filed 2023-02-23
2021-03-31$31.00K
10-Q · filed 2022-05-12
2020-12-31$1.00K
10-Q · filed 2021-02-16
2020-06-30$157.00K
derived: 10-KT 12 month − 10-Q 9 month · filed 2022-02-28
$474.00K
10-KT · filed 2022-02-28
2020-03-31$69.00K
10-Q · filed 2021-05-13
2019-12-31$248.00K
10-Q · filed 2021-02-16
2019-06-30$335.00K
10-K · filed 2021-08-26